Evidence map›Paper›PMID 25925128›Full record

ArticleAdvanced healthcare materials2015

Single-Step Assembly of Multimodal Imaging Nanocarriers: MRI and Long-Wavelength Fluorescence Imaging.

Nathalie M Pinkerton, Marian E Gindy, Victoria L Calero-DdelC, Theodore Wolfson, Robert F Pagels, Derek Adler, Dayuan Gao, Shike Li, Ruobing Wang, Margot Zevon and 6 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Flame-Made Doped Iron Oxide Nanoparticles as Tracers for Magnetic Particle Imaging.Chemistry of materials : a publication of the American Chemical Society · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. The clearance and biodistribution of magnetic composite nanoparticles in healthy and osteoarthritic rat knees.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nathalie M PinkertonDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, 08544, USA.
Marian E GindyDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, 08544, USA.
Victoria L Calero-DdelCDepartment of Chemical Engineering, University of Puerto Rico, Mayagüez, 00681, Puerto Rico.
Theodore WolfsonDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, 08544, USA.
Robert F PagelsDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, 08544, USA.
Derek AdlerCollege of Pharmacy, Rutgers University, Piscataway, NJ, 08854, USA.
Dayuan GaoCollege of Pharmacy, Rutgers University, Piscataway, NJ, 08854, USA.
Shike LiCollege of Pharmacy, Rutgers University, Piscataway, NJ, 08854, USA.
Ruobing WangDepartment of Chemistry, Duke University, Durham, NC, 27708, USA.
Margot ZevonDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ, 08854, USA.
Nan YaoPrinceton Materials Institute, Princeton University, Princeton, NJ, 08540, USA.
Carlos PachecoDepartment of Chemistry, University of Connecticut, Storrs, CT, 06269, USA.
Michael J TherienDepartment of Chemistry, Duke University, Durham, NC, 27708, USA.
Carlos RinaldiJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, 32605, USA.
Patrick J SinkoCollege of Pharmacy, Rutgers University, Piscataway, NJ, 08854, USA.
Robert K Prud'hommeDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, 08544, USA.

Funding

UMDNJ/Rutgers University CounterACT Research Center of ExcellenceU54AR055073 · NIAMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI HECK, DIANE E · 2006 to 2024
$71.4M
ANTI-HIV COLORECTAL NANOCARRIER-BASED FOAMS FOR MUCOSAL PRE-EXPOSURE PROPHYLAXISR01AI117776 · NIAID · RUTGERS, THE STATE UNIV OF N.J. · PI SINKO, PATRICK J. · 2015 to 2018
$2.1M
Multifunctional PEG Hydrogel Nano/Microparticles for Targeted Treatment of NSCLCR01CA155061 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI SINKO, PATRICK J. · 2011 to 2015
$1.8M
Multiplex Nanocarrier-based Hydrogels for Prevention of Vaginal HIV Transmission.R01AI084137 · NIAID · RUTGERS, THE STATE UNIV OF N.J. · PI SINKO, PATRICK J. · 2009 to 2012
$1.5M
NCI NIH HHS 1R01CA155061-1NCI NIH HHS R01 CA155061NIAID NIH HHS R01 AI084137NIAID NIH HHS R01 AI117776NIAMS NIH HHS U54AR055073
6 · The paper itself

Abstract

Magnetic resonance imaging (MRI)- and near-infrared (NIR)-active, multimodal composite nanocarriers (CNCs) are prepared using a simple one-step process, flash nanoprecipitation (FNP). The FNP process allows for the independent control of the hydrodynamic diameter, co-core excipient and NIR dye loading, and iron oxide-based nanocrystal (IONC) content of the CNCs. In the controlled precipitation process, 10 nm IONCs are encapsulated into poly(ethylene glycol) (PEG) stabilized CNCs to make biocompatible T2 contrast agents. By adjusting the formulation, CNC size is tuned between 80 and 360 nm. Holding the CNC size constant at an intensity weighted average diameter of 99 ± 3 nm (PDI width 28 nm), the particle relaxivity varies linearly with encapsulated IONC content ranging from 66 to 533 × 10(-3) m(-1) s(-1) for CNCs formulated with 4-16 wt% IONC. To demonstrate the use of CNCs as in vivo MRI contrast agents, CNCs are surface functionalized with liver-targeting hydroxyl groups. The CNCs enable the detection of 0.8 mm(3) non-small cell lung cancer metastases in mice livers via MRI. Incorporating the hydrophobic, NIR dye tris-(porphyrinato)zinc(II) into CNCs enables complementary visualization with long-wavelength fluorescence at 800 nm. In vivo imaging demonstrates the ability of CNCs to act both as MRI and fluorescent imaging agents.

Indexed as

Contrast MediaDrug CarriersFerric CompoundsAnimalsFluorescent DyesMagnetic Resonance ImagingMiceNanoparticlesOptical ImagingParticle SizePolyethylene GlycolsContrast MediaDrug CarriersFerric Compoundsferric oxideFluorescent Dyespolyethylene glycol 1000Polyethylene Glycolscomposite nanocarrierflash nanoprecipitationmetastasis detectionMRI contrast agentsmultimodal imaging

Identifiers

PMID25925128
PMCPMC4617688

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.